Yao Q, Liu Z
Clin Cosmet Investig Dermatol. 2024; 17:1999-2007.
PMID: 39247134
PMC: 11380861.
DOI: 10.2147/CCID.S481939.
Ivask M, Kurvits K, Uuskula M, Juppo A, Laius O, Siven M
Drugs Real World Outcomes. 2023; 11(1):91-98.
PMID: 37462893
PMC: 10928043.
DOI: 10.1007/s40801-023-00381-3.
Hughes J, Buckley N, Looney Y, Kirwan G, Mullooly M, Bennett K
Pharmacoepidemiol Drug Saf. 2022; 32(2):137-147.
PMID: 36073295
PMC: 10092126.
DOI: 10.1002/pds.5538.
Naik P
Dermatol Res Pract. 2022; 2022:1504303.
PMID: 35668721
PMC: 9166940.
DOI: 10.1155/2022/1504303.
Sun Y, Zhang J, Wang Y, Wang L, Song M, Khan A
Cell Cycle. 2021; 20(22):2372-2386.
PMID: 34779712
PMC: 8794519.
DOI: 10.1080/15384101.2021.1982506.
Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling.
Green D, Park K, Bhatt-Mehta V, Snyder D, Burckart G
Front Pediatr. 2021; 9:698611.
PMID: 34381745
PMC: 8350126.
DOI: 10.3389/fped.2021.698611.
Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris.
Brumfiel C, Patel M, Bell K, Cardis M
Ther Clin Risk Manag. 2021; 17:755-763.
PMID: 34345173
PMC: 8324978.
DOI: 10.2147/TCRM.S286953.
Awareness on Teratogenic Effects of Isotretinoin and Compliance with Precautionary Measures among Women of Childbearing Age in Makkah Province, Saudi Arabia.
Al-Mekhlafi R, Attiyah R, Haddad Y, Salah L
Obstet Gynecol Int. 2021; 2021:9966300.
PMID: 33936210
PMC: 8055435.
DOI: 10.1155/2021/9966300.
Using Natural Language Processing to Examine the Uptake, Content, and Readability of Media Coverage of a Pan-Canadian Drug Safety Research Project: Cross-Sectional Observational Study.
Mohammadhassanzadeh H, Sketris I, Traynor R, Alexander S, Winquist B, Stewart S
JMIR Form Res. 2020; 4(1):e13296.
PMID: 31934872
PMC: 6996767.
DOI: 10.2196/13296.
Micronutrient supplementation in pregnancy: Who, what and how much?.
Parisi F, di Bartolo I, Savasi V, Cetin I
Obstet Med. 2019; 12(1):5-13.
PMID: 30891086
PMC: 6416688.
DOI: 10.1177/1753495X18769213.
CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations.
Okuno H, Renault Mihara F, Ohta S, Fukuda K, Kurosawa K, Akamatsu W
Elife. 2017; 6.
PMID: 29179815
PMC: 5705211.
DOI: 10.7554/eLife.21114.
Melanoma Chemoprevention: Current Status and Future Prospects.
Chhabra G, Ndiaye M, Garcia-Peterson L, Ahmad N
Photochem Photobiol. 2017; 93(4):975-989.
PMID: 28295364
PMC: 5500429.
DOI: 10.1111/php.12749.
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.
Henry D, Dormuth C, Winquist B, Carney G, Bugden S, Teare G
CMAJ. 2016; 188(10):723-730.
PMID: 27114489
PMC: 4938682.
DOI: 10.1503/cmaj.151243.
Developments in our understanding of the genetic basis of birth defects.
Webber D, MacLeod S, Bamshad M, Shaw G, Finnell R, Shete S
Birth Defects Res A Clin Mol Teratol. 2015; 103(8):680-91.
PMID: 26033863
PMC: 4537658.
DOI: 10.1002/bdra.23385.
Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
Zomerdijk I, Ruiter R, Houweling L, Herings R, Sturkenboom M, Straus S
BMJ Open. 2014; 4(11):e005602.
PMID: 25392022
PMC: 4244495.
DOI: 10.1136/bmjopen-2014-005602.
Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
Lagan B, Dolk H, White B, Uges D, Sinclair M
Pharmacoepidemiol Drug Saf. 2014; 23(4):411-8.
PMID: 24493556
PMC: 4265198.
DOI: 10.1002/pds.3565.
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
Crijns I, Straus S, Luteijn M, Wied C, Raine J, de Jong-van den Berg L
Drug Saf. 2011; 35(1):27-32.
PMID: 22050373
DOI: 10.2165/11595570-000000000-00000.
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.
Crockett S, Porter C, Martin C, Sandler R, Kappelman M
Am J Gastroenterol. 2010; 105(9):1986-93.
PMID: 20354506
PMC: 3073620.
DOI: 10.1038/ajg.2010.124.
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.
Berard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D
Br J Clin Pharmacol. 2007; 63(2):196-205.
PMID: 17214828
PMC: 1859978.
DOI: 10.1111/j.1365-2125.2006.02837.x.
Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?.
Azoulay L, Oraichi D, Berard A
Eur J Clin Pharmacol. 2006; 62(8):667-74.
PMID: 16791584
DOI: 10.1007/s00228-006-0151-x.
